Summit Therapeutics Inc. Number Of Share Options Exercised In Share-based Payment Arrangement
Summit Therapeutics Inc. (SMMT) reported Number Of Share Options Exercised In Share-based Payment Arrangement of 0 shares for the 11-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement · last filed 2020-04-30
- Summit Therapeutics Inc. number of share options exercised in share-based payment arrangement for the quarter ending 2019-10-31 was 0.00 shares.
- Summit Therapeutics Inc. number of share options exercised in share-based payment arrangement for the quarter ending 2019-07-31 was 0.00 shares.
- Summit Therapeutics Inc. number of share options exercised in share-based payment arrangement for the quarter ending 2019-04-30 was 0.00 shares, a 100.00% decline year-over-year.
- Summit Therapeutics Inc. number of share options exercised in share-based payment arrangement for the quarter ending 2019-01-31 was 0.00 shares.
| Period end | Number Of Share Options Exercised In Share-based Payment Arrangement | Number Of Share Options Exercised In Share-based Payment Arrangement 3 month | Number Of Share Options Exercised In Share-based Payment Arrangement 6 month | Number Of Share Options Exercised In Share-based Payment Arrangement 9 month | Number Of Share Options Exercised In Share-based Payment Arrangement 11 month | Number Of Share Options Exercised In Share-based Payment Arrangement 12 month |
|---|---|---|---|---|---|---|
| 2019-12-31 | 0.00 shares 20-F · filed 2020-04-30 | |||||
| 2019-10-31 | 0.00 shares derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | 0.00 shares derived: sum of 2 quarters · filed 2019-12-17 | 0.00 shares 6-K · filed 2019-12-17 | 0.00 shares derived: sum of 4 quarters · filed 2020-04-30 | ||
| 2019-07-31 | 0.00 shares derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | 0.00 shares 6-K · filed 2019-10-11 | 0.00 shares derived: sum of 3 quarters · filed 2020-04-30 | 0.00 shares derived: sum of 4 quarters · filed 2020-04-30 | ||
| 2019-04-30 | 0.00 shares 6-K · filed 2019-06-12 | 0.00 shares derived: sum of 2 quarters · filed 2020-04-30 | 0.00 shares derived: sum of 3 quarters · filed 2020-04-30 | 0.00 shares derived: sum of 4 quarters · filed 2020-04-30 | ||
| 2019-01-31 | 0.00 shares derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | 0.00 shares derived: sum of 2 quarters · filed 2020-04-30 | 0.00 shares derived: sum of 3 quarters · filed 2020-04-30 | 92.05K shares 20-F · filed 2020-04-30 | ||
| 2018-10-31 | 0.00 shares derived: 6-K 9 month − 6-K 6 month · filed 2019-12-17 | 0.00 shares derived: sum of 2 quarters · filed 2019-12-17 | 92.05K shares 6-K · filed 2019-12-17 | 92.05K shares derived: sum of 4 quarters · filed 2019-12-17 | ||
| 2018-07-31 | 0.00 shares derived: 6-K 6 month − 6-K 3 month · filed 2019-10-11 | 92.05K shares 6-K · filed 2019-10-11 | 92.05K shares derived: sum of 3 quarters · filed 2019-10-11 | 404.49K shares derived: sum of 4 quarters · filed 2019-10-11 | ||
| 2018-04-30 | 92.05K shares 6-K · filed 2019-06-12 | 92.05K shares derived: sum of 2 quarters · filed 2019-06-12 | 404.49K shares derived: sum of 3 quarters · filed 2019-06-12 | 423.92K shares derived: sum of 4 quarters · filed 2019-06-12 | ||
| 2018-04-23 | 48.98K shares 6-K · filed 2018-06-05 | |||||
| 2018-04-18 | 38.85K shares 6-K · filed 2018-06-05 | |||||
| 2018-03-16 | 4.22K shares 6-K · filed 2018-06-05 | |||||
| 2018-01-31 | 0.00 shares derived: 20-F 12 month − 6-K 9 month · filed 2019-03-29 | 312.44K shares derived: sum of 2 quarters · filed 2019-03-29 | 331.87K shares derived: sum of 3 quarters · filed 2019-03-29 | 348.54K shares 20-F · filed 2019-03-29 | ||
| 2017-10-31 | 312.44K shares derived: 6-K 9 month − 6-K 6 month · filed 2018-12-11 | 331.87K shares derived: sum of 2 quarters · filed 2018-12-11 | 348.54K shares 6-K · filed 2018-12-11 | |||
| 2017-10-04 | 88.32K shares 20-F · filed 2018-04-13 | |||||
| 2017-10-02 | 97.20K shares 20-F · filed 2018-04-13 | |||||
| 2017-09-29 | 94.42K shares 20-F · filed 2018-04-13 | |||||
| 2017-09-28 | 32.50K shares 20-F · filed 2018-04-13 | |||||
| 2017-07-31 | 19.43K shares derived: 6-K 6 month − 6-K 3 month · filed 2018-09-20 | 36.09K shares 6-K · filed 2018-09-20 | ||||
| 2017-06-27 | 19.43K shares 20-F · filed 2018-04-13 | |||||
| 2017-04-30 | 16.67K shares 6-K · filed 2018-06-05 | |||||
| 2017-04-10 | 16.67K shares 20-F · filed 2018-04-13 | |||||
| 2017-01-31 | 373.78K shares 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |